Literature DB >> 1026529

The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.

J W Ward, G R Kinghorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026529

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  24 in total

1.  The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Authors:  J L Cunningham; D D Shen; I Shudo; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 2.  Effects of cardiovascular disease on pharmacokinetics.

Authors:  V Rodighiero
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

3.  Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.

Authors:  J S Birkhead; E M Vaughan Williams
Journal:  Br Heart J       Date:  1977-06

4.  Role of concentration-dependent plasma protein binding in disopyramide disposition.

Authors:  P J Meffin; E W Robert; R A Winkle; S Harapat; F A Peters; D C Harrison
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

5.  Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].

Authors:  J J Ashford; D Carmichael; P H Kidner
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

6.  Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.

Authors:  K M Giacomini; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of disopyramide.

Authors:  L A Siddoway; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

8.  The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.

Authors:  K M Giacomini; S E Swezey; K Turner-Tamiyasu; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

9.  Disopyramide in acute myocardial infarction: problems with changing pharmacokinetics.

Authors:  H L Elliott; A H Thomson; S M Bryson
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Disopyramide pharmacokinetics during recovery from myocardial infarction.

Authors:  S M Bryson; C J Cairns; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.